BB&T Investment Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.15M Buy
61,995
+9,489
+18% +$324K 0.36% 67
2017
Q3
$1.8M Buy
52,506
+10,076
+24% +$324K 0.36% 65
2017
Q2
$1.36M Buy
42,430
+6,367
+18% +$201K 0.34% 66
2017
Q1
$1.17M Sell
36,063
-2,564
-7% -$80.8K 0.46% 40
2016
Q4
$1.19M Buy
+38,627
New +$1.18M 0.87% 24

Other funds holding PFE

BB&T Investment Services's PFE Position: Q4 2017 in Review

BB&T Investment Services increased its Pfizer (PFE) stake by 18% in Q4 2017, buying an estimated $324K and bringing the position to 61,995 shares worth $2.15M. The position accounts for 0.36% of the portfolio, ranked #67.

BB&T Investment Services first reported a position in PFE in Q4 2016 and has held it in 5 quarters since. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • BB&T Investment Services held 61,995 shares of Pfizer worth $2.15M as of Q4 2017.
  • BB&T Investment Services bought 9,489 Pfizer shares in Q4 2017, an estimated $324K.
  • Pfizer made up 0.36% of BB&T Investment Services's portfolio in Q4 2017, its #67 holding.
  • BB&T Investment Services first reported a position in Pfizer in Q4 2016 and has held it in 5 quarters since.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.